• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

insulin

Medtronic, Tandem Diabetes Care bury the hatchet on potential IP disputes

July 9, 2020 By Chris Newmarker

Medtronic Tandem Diabetes Care

Two major insulin pump makers — Medtronic (NYSE:MDT) and Tandem Diabetes Care (NSDQ:TNDM) — announced today that they’ve inked a non-exclusive patent cross-license agreement related to diabetes treatment tech. The companies said the agreement will allow them to focus on innovation while avoiding the distraction of potential legal disagreements. The deal could be but another example of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News Tagged With: Abbott Laboratories, insulin, Tandem Diabetes Care

This coin-sized insulin patch could improve diabetes treatment

March 6, 2020 By Chris Newmarker

adhesive microneedle coin-sized insulin patch UCLA diabetes

Could treating diabetes someday be as simple as slapping on a patch? A UCLA-led research team thinks so, and it’s seeking FDA permission to prove it. A research team led by UCLA bioengineering professor Zhen Gu claims to have overcome some of the technological hurdles around creating a patch that releases insulin based on the […]

Filed Under: Diabetes, Drug-Device Combinations Tagged With: insulin, UCLA, Zenomics

Insulet’s Omnipod Dash Personal Diabetes Managers have a glitch

February 13, 2020 By Chris Newmarker

Insulet Ominipod Dash Personal Diabetes Managers

Insulet (NSDQ:PODD) is issuing a voluntary medical device correction for all of the smartphone-like Personal Diabetes Managers that came with its next-gen Omnipod Dash insulin management system, the company announced today. During its ongoing quality management process, Insulet officials discovered that the PDMs on rare occasions will suggest an inaccurate bolus amount based on a blood […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Recalls Tagged With: Insulet, insulin

FDA says Medtronic MiniMed insulin pump recall is serious

February 12, 2020 By Chris Newmarker

Medtronic Minimed 630g

The U.S. FDA has designated a recall of hundreds of thousands of Medtronic Minimed insulin pumps as Class I — the most serious type of recall. Medtronic (NYSE:MDT) first warned of safety problems with the pumps in November. The recall involves 322,005 pumps — MiniMed 630G (model MMT-1715) and MiniMed 670G (model MMT-1780) — in the […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Recalls Tagged With: insulin, Medtronic

Abbott boosts support for Bigfoot Biomedical and its diabetes treatment tech

January 13, 2020 By Chris Newmarker

Bigfoot Biomedical Abbott Bigfoot Unity diabetes management program Insulet acquires Bigfoot assets

Diabetes treatment tech company Bigfoot Biomedical has raised another $45 million in the initial tranche of a Series C equity financing, with collaborator Abbott (NYSE:ABT)  as the lead investor. “We are excited to announce Abbott’s deepening support of Bigfoot Biomedical with this Series C financing,” Bigfoot Biomedical CEO Jeffrey Brewer said in a news release today.  […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Abbott Laboratories, artificial pancreas, Bigfoot Biomedical, insulin

9 diabetes breakthroughs you need to know

May 25, 2017 By Danielle Kirsh

Diabetes is a disease that affects the body’s ability to produce and respond to insulin. About 29.1 million people have diabetes in the U.S, according to the Centers for Disease Control and Prevention. Of that number, 8.1 million go undiagnosed. One of the most popular breakthroughs in diabetes research has been the artificial pancreas, which […]

Filed Under: Diabetes, Diagnostics, Featured, Research & Development Tagged With: Afrezza, Apple Inc., beta cells, Diabetes, insulin, medtech

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS